Breaking News Instant updates and real-time market news.

AMD

AMD

$8.69

-0.25 (-2.80%)

, WMT

Wal-Mart

$70.12

0.75 (1.08%)

07:35
11/23/16
11/23
07:35
11/23/16
07:35

Unusual call flow in option market yesterday

Notable call activity was cited Tuesday in AMD (AMD), Wal-Mart (WMT), AK Steel (AKS), Cliffs Natural (CLF), Whiting Petroleum (WLL), Best Buy (BBY), Cognizant (CTSH), Synchrony (SYF), Enterprise Products (EPD), and Monster Beverage (MNST).

AMD

AMD

$8.69

-0.25 (-2.80%)

WMT

Wal-Mart

$70.12

0.75 (1.08%)

AKS

AK Steel

$8.89

0.86 (10.71%)

CLF

Cliffs Natural

$8.64

1.1 (14.59%)

WLL

Whiting Petroleum

$10.12

-0.11 (-1.08%)

BBY

Best Buy

$46.60

0.95 (2.08%)

CTSH

Cognizant

$53.18

-1.92 (-3.48%)

SYF

Synchrony

$33.97

0.35 (1.04%)

EPD

Enterprise Products

$25.66

0.04 (0.16%)

MNST

Monster Beverage

$45.26

1.67 (3.83%)

  • 28

    Nov

  • 01

    Dec

  • 06

    Dec

AMD AMD
$8.69

-0.25 (-2.80%)

11/22/16
MKMP
11/22/16
NO CHANGE
MKMP
Buy
MKM Partners raises NVIDIA, AMD price targets on inflecting semi opportunities
MKM Partners analyst Ian Ing raised his price target for NVIDIA (NVDA) to $106 from $87, saying that thematic attention is heating up as large suppliers are crowding into artificial intelligence as an investment theme with non-GPU solutions. While other suppliers may be able to come up with better performance-for-power in certain use cases, he believes NVIDIA GPUs still have user stickiness with developer incumbency and easy-to-use tools that will be difficult to overcome. The analyst also raised his price target for AMD (AMD) to $10.50 from $8 to reflect improved prospects for the company driven by new product pipeline. Although Ian expects AMD to be a relatively minor player, its shares are helped by continued A.I. headlines and NVIDIA, Intel (INTC), and Qualcomm (QCOM) turning increasingly vocal on the opportunity. He reiterates a Buy rating on NVIDIA and AMD shares.
10/21/16
BERN
10/21/16
NO CHANGE
BERN
AMD outlook 'sounds promising,' says Bernstein
Bernstein analyst Stacy Rasgon says that AMD's Q3 results were "strong," and the analyst says that the comments and evidence presented by the company about its design wins and engagements "sound promising." Rasgon says she's weary about AMD, given its past missteps, but the analyst admits that she "just might be warming up to the story." Rasgon raised her price target on the shares to $7.50 from $6 but keeps a Market Perform rating on the stock.
10/21/16
SBSH
10/21/16
NO CHANGE
Target $3.5
SBSH
Sell
AMD continues to lose money, says Citi
Citi analyst Christopher Danely keeps a Sell rating on AMD following the company's Q3 results. AMD continues to lose money despite improving fundamentals with estimated net debt of $353.3M, Danely tells investors in a research note. He raised his price target for the shares to $3.50 from $2.50.
10/21/16
ADAM
10/21/16
NO CHANGE
Target $9
ADAM
Buy
AMD weakness a buying opportunity, says Canaccord
Canaccord analyst Matthew Ramsay said AMD reported "solid" Q3 results and provided seasonally lower guidance, which was expected. The analyst said his buy thesis remains intact and the selloff in the after hours was unwarranted. Ramsay said the weakness in the shares is a buying opportunity with the risk/reward tilted toward the upside upon entering an important year for the company's turnaround. Ramsay reiterated his Buy rating and $8.50 price target on AMD shares.
WMT Wal-Mart
$70.12

0.75 (1.08%)

11/23/16
UBSW
11/23/16
NO CHANGE
Target $100
UBSW
Buy
Dollar Tree price target raised to $100 from $90 at UBS
UBS analyst Michael Lasser raised his price target on Dollar Tree (DLTR) to $100 from $90 following Q3 results. The analyst said the company's results eased a number of fears and demonstrated it could hold its own against competitors such as Wal-Mart (WMT). Dollar Tree exhibited comp growth, and its merger with Family dollar is providing synergies within its guidance, said Lasser, who reiterated his Buy rating on the shares.
10/27/16
JPMS
10/27/16
DOWNGRADE
Target $28
JPMS
Neutral
JPMorgan downgrades Vitamin Shoppe on 2017 earnings risk
JPMorgan analyst Christopher Horvers earlier today downgraded Vitamin Shoppe (VSI) to Neutral from Overweight and lowered his price target for the shares to $28 from $33. The analyst sees downside risk to 2017 earnings as the competitive environment worsens. GNC Holdings (GNC) under new management is testing major pricing and loyalty card changes while Vitamin Shoppe's comparable prices are higher versus Amazon (AMZN), Horvers tells investors in a research note. He sees Vitamin Shoppe "squeezed between" its three larger competitors, GNC, Wal-Mart (WMT) and Amazon. The stock is trading down $2.05 to $25.30 following GNC's Q3 results. GNC is trading down 20% to $16.04.
11/11/16
BARD
11/11/16
NO CHANGE
Target $80
BARD
Outperform
Wal-Mart 2017 earnings somewhat de-risked, says Baird
Baird analyst Peter Benedict expects Wal-Mart's Q3 results to be generally in-line as investments in associates, processes, and prices are working together to drive improved customer satisfaction and sales. The company's 2017 estimates appear to be de-risked as management reset margin and earnings expectations at last month's investor meeting, said Benedict, who reiterated his Outperform rating and $80 price target on Wal-Mart shares.
11/17/16
BARD
11/17/16
NO CHANGE
Target $80
BARD
Outperform
Wal-Mart strategy remains on track, says Baird
Baird analyst Peter Benedict notes that this was a 'noisy' quarter for Wal-Mart, but underlying EPS effectively in line with expectations. While acknowledging that U.S. traffic gains slowed against a tougher compare and Q4 EPS guidance was viewed as a disappointment, the analyst believes Wal-Mart's strategy remains on track and 2017 EPS estimates appear largely de-risked. He reiterates an Outperform rating and $80 price target on the shares, given the company's defensive appeal within a still choppy consumer/retail backdrop.
AKS AK Steel
$8.89

0.86 (10.71%)

11/14/16
MSCO
11/14/16
UPGRADE
Target $11
MSCO
Overweight
AK Steel upgraded on upside to infrastructure cycle at Morgan Stanley
Morgan Stanley analyst Evan Kurtz upgraded AK Steel to Overweight from Equal Weight and raised its price target to $11 from $5. The analyst believes the Trump victory has led to the first "credible long-term investment case" for steel equities for the first time in a decade and expects Trump's proposals for infrastructure spending and trade protection to add to demand and curb import supply. Kurtz expects AK Steel to benefit from increased flat-rolled steel demand, ongoing cost savings, and leverage to an infrastructure upcycle.
11/14/16
MSCO
11/14/16
UPGRADE
MSCO
Overweight
AK Steel upgraded to Overweight from Equal Weight at Morgan Stanley
11/09/16
JEFF
11/09/16
UPGRADE
Target $20
JEFF
Buy
Commercial Metals upgraded to Buy from Hold at Jefferies
Jefferies analyst Seth Rosenfeld upgraded Commercial Metals (CMC) to Buy saying the U.S. steel industry "should stand out as a unique beneficiary of a Trump presidency." Steal names should benefit from rising protectionist trade policy, Rosenfeld tells investors in a research note. Falling imports will improve domestic pricing power while increased infrastructure spend "may significantly boost" demand for long steel products, the analyst contends. He raised his price target for Commercial Metals shares to $20. Rosenfeld this morning also upgraded U.S. Steel (X) and keeps a Buy rating on AK Steel (AKS).
11/14/16
11/14/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Lockheed Martin (LMT) upgraded to Buy from Hold at Stifel with analyst Joseph DeNardi saying he is pleased with the company's comments regarding its 2018 free cash flow outlook, and he thinks that it could benefit from increased defense spending in the wake of the election results. 2. Philip Morris (PM) upgraded to Buy from Outperform at CLSA with analyst Michael Levy citing the recent pullback for his rating change and said he sees the company adding to its buyback. 3. Citi (C) upgraded to Overweight from Equal Weight at Morgan Stanley with analysts led by Betsy Graseck saying the Republican sweep is positive for all financial stocks due to increased growth, higher rates, lower taxes, and less regulation. 4. U.S. Steel (X) and AK Steel (AKS) upgraded to Overweight from Equal Weight at Morgan Stanley. 5. L Brands (LB), Kohl's (KSS), and Chico's(CHS) were upgraded to Buy from Neutral at Citi, while Chico's was also upgraded to Outperform from Peer Perform at Wolfe Research. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
CLF Cliffs Natural
$8.64

1.1 (14.59%)

11/14/16
MSCO
11/14/16
UPGRADE
Target $9
MSCO
Equal Weight
Cliffs Natural upgraded to Equal Weight from Underweight at Morgan Stanley
Morgan Stanley analyst Evan Kurtz upgraded Cliffs Natural to Equal Weight and raised its price target to $9 from $3. The analyst believes the Trump victory has led to the first "credible long-term investment case" for steel equities for the first time in a decade and expects Trump's proposals for infrastructure spending and trade protection to add to demand and curb import supply. Kurtz said Cliffs is leveraged to HRC steel prices ad will benefit from higher blast furnace operating rates.
07/18/16
CLKS
07/18/16
UPGRADE
CLKS
Neutral
Cliffs Natural upgraded to Neutral from Sell at Clarksons Platou
07/12/16
JPMS
07/12/16
NO CHANGE
Target $10.5
JPMS
Overweight
Cliffs Natural price target raised to $10.50 from $7 at JPMorgan
JPMorgan analyst Michael Gambardella raised his price target for Cliffs Natural Resources to $10.50 and keeps an Overweight rating on the name. The recent bankruptcy of Essar Steel Minnesota has further solidified Cliffs' "defensible business model," Gambardella tells investors in a research note. The short interest in the name, at 43% of outstanding float, is "extremely high despite the wave of positive developments," the analyst contends. He sees a likely positive catalyst from near-term earnings beats amid higher steel pricing.
10/07/16
FBCO
10/07/16
INITIATION
Target $2
FBCO
Underperform
Cliffs Natural reinstated with an Underperform at Credit Suisse
Credit Suisse analyst Curt Woodworth reinstated Cliffs Natural with an Underperform and a $2 price target primarily due to a bearish view on iron ore.
WLL Whiting Petroleum
$10.12

-0.11 (-1.08%)

10/28/16
SPHN
10/28/16
UPGRADE
SPHN
Overweight
Whiting Petroleum upgraded to Overweight from Equal Weight at Stephens
Stephens analyst Will Green upgraded Whiting Petroleum to Overweight from Equal Weight, saying that the "worst may be behind" for the company.
10/10/16
RHCO
10/10/16
NO CHANGE
RHCO
Whiting Petroleum named top pick at SunTrust
SunTrust analyst Neal Dingmann named Whiting Petroleum as his top pick. The analyst says that recent developments at the company should enable its production to remain "at least flat," while the company should get a big boost from recent oil price rises.
10/28/16
RAJA
10/28/16
UPGRADE
Target $16
RAJA
Strong Buy
Whiting Petroleum upgraded to Strong Buy from Outperform at Raymond James
Raymond James analyst John Freeman upgraded Whiting Petroleum to Strong Buy and raised its price target to $16 from $14. The analyst said Whiting reported "extremely impressive" Q3 report and now plans to double its Bakken rig count and sees double-digit production growth from current levels in 2017.
10/05/16
MZHO
10/05/16
INITIATION
Target $9
MZHO
Neutral
Whiting Petroleum initiated with a Neutral at Mizuho
Mizuho analyst Timothy Rezvan initiated Whiting Petroleum with a Neutral and a $9 price target.
BBY Best Buy
$46.60

0.95 (2.08%)

11/18/16
WEDB
11/18/16
NO CHANGE
WEDB
Best Buy outlook remains negative, says Wedbush
After Best Buy reported stronger than expected results, Wedbush analyst Michael Pachter still expects the company's holiday sales to be hurt by weakness in TV and wearables. The analyst says the fact that the company does not plan to issue a press release on its holiday sales bodes badly for its performance. He keeps a $24.50 price target and an Underperform rating on the shares.
11/17/16
BOFA
11/17/16
UPGRADE
BOFA
Neutral
Best Buy upgraded to Neutral from Underperform at BofA/Merrill
11/17/16
11/17/16
UPGRADE
Target $49

Neutral
Best Buy upgraded to Neutral after 'strong' Q3 at BofA/Merrill
As previously reported, BofA Merrill Lynch analyst Denise Chai upgraded Best Buy to Neutral from Underperform, saying that its latest quarterly results and share gains prove management's execution continues to be "extremely strong." However, she did not raise the stock to a Buy, citing its valuation and the fact that the company's guidance for the holiday quarter "was not particularly positive." Chai raised her price target on the stock to $49 from $29.
11/18/16
UBSW
11/18/16
NO CHANGE
Target $47
UBSW
Neutral
Best Buy fairly valued at current levels, says UBS
UBS analyst Michael Lasser noted Best Buy continued to outperform and take market share in Q3. He said the market share gains drove solid comp growth during the quarter and believes increasing its international operating margins is a long-term opportunity for the company. Lasser feels Best Buy shares are fairly valued at current levels and reiterated his Neutral rating while raising his price target on the shares to $47 from $38.
CTSH Cognizant
$53.18

-1.92 (-3.48%)

10/31/16
KEYB
10/31/16
NO CHANGE
KEYB
Cognizant should report upbeat earnings, says KeyBanc
KeyBanc says that Cognizant can increase investor confidence by "clarifying the impact from potential FCPA violations and President Gordon Coburn's abrupt departure." The firm thinks that the company's negative comments and lowered guidance are priced into the stock at current levels. It believes that the set-up for the company heading into its Q3 results is positive. The firm reiterates a $67 price target and an Overweight rating on the shares.
11/23/16
WBLR
11/23/16
DOWNGRADE
WBLR
Market Perform
Cognizant downgraded to Market Perform from Outperform at William Blair
William Blair analyst Anil Doradla downgraded Cognizant Technology Solutions to Market Perform.
11/22/16
BOFA
11/22/16
DOWNGRADE
BOFA
Underperform
Cognizant downgraded two notches to Underperform at BofA/Merrill
BofA/Merrill analyst David Ridley-Lane downgraded Cognizant two notches to Underperform from Buy and lowered its price target to $48 from $66. The analyst sees risks from potential immigration reform under a Trump administration and a slower growth profile. Further, Ridley-Lane said revenue growth at Cognizant's largest customers has stalled and views a reacceleration of growth in 2017 as unlikely.
10/03/16
DBAB
10/03/16
NO CHANGE
Target $69
DBAB
Buy
Deutsche says Cognizant fundamentals unlikely hurt by probe and executive change
Deutsche Bank analyst Bryan Keane said that Cognizant's internal investigation on improper payments made in India, while clearly a negative, is similar to fines and issues encountered by other U.S. multinationals conducting business in India. Also, Keane believes the resignation of President Gordon Coburn is "larger to the investment community than it is internally." After speaking to CFO Karen McLoughlin, Keane does not see any change in Cognizant's fundamental position and keeps a Buy rating with a $69 price target on the shares.
SYF Synchrony
$33.97

0.35 (1.04%)

11/18/16
SPHN
11/18/16
INITIATION
Target $40
SPHN
Overweight
Synchrony initiated with an Overweight at Stephens
Stephens analyst Vincent Caintic started Synchrony with an Overweight rating and $40 price target.
11/18/16
11/18/16
INITIATION
Target $40

Overweight
Synchrony initiated with an Overweight at Stephens
As previously reported, Stephens analyst Vincent Caintic started Synchrony (SYF) with an Overweight rating and $40 price target, citing $5B excess capital that allows Synchrony to buy back 20% of company once capital return is deregulated, industry retail share weakness, and revenue growth. The analyst also started American Express (AXP) and Discover (DFS) with an Underweight rating.
11/18/16
11/18/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Cisco (CSCO) coverage resumed with a Hold at Stifel. 2. UPS (UPS) was initiated with an Outperform at BMO Capital while the firm initiated FedEx (FDX) with a Market Perform. 3. Synchrony (SYF) was initiated with an Overweight at Stephens. The firm also initiated American Express (AXP) and Discover (DFS) with an Underweight. 4. American Airlines (AAL), Delta Air Lines (DAL), Southwest (LUV) and Allegiant Travel (ALGT) were initiated with a Buy at Citi while the firm initiated JetBlue (JBLU), United Continental (UAL), Alaska Air (ALK), and Hawaiian Holdings (HA) with a Neutral. 5. Juniper (JNPR) coverage resumed at Stifel. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/08/16
MSCO
11/08/16
NO CHANGE
Target $33
MSCO
Overweight
Synchrony is a top pick with upside to $33, says Morgan Stanley
Morgan Stanley analyst Betsy Graseck said Outperform rated Synchrony is a top pick with upside to $33 given 14% earnings growth in 2017, low valuation, and lower RSAs that reduce credit related earnings volatility.
EPD Enterprise Products
$25.66

0.04 (0.16%)

10/07/16
WOLF
10/07/16
INITIATION
Target $30
WOLF
Outperform
Enterprise Products initiated with an Outperform at Wolfe Research
Wolfe Research analyst Steven Fleishman initiated Enterprise Products with an Outperform and a $30 price target.
09/19/16
FBCO
09/19/16
UPGRADE
Target $34
FBCO
Outperform
Enterprise Products upgraded to Outperform from Neutral at Credit Suisse
Credit Suisse analyst John Edwards upgraded Enterprise Products to Outperform and maintained its $34 price target saying the price correction offers an attractive entry point into a long-term core holding. He believes the company offers solid risk/reward given its conservative distribution policy, high quality and interconnected asset footprint, and a best in class management team.
09/29/16
MZHO
09/29/16
INITIATION
Target $32
MZHO
Buy
Enterprise Products initiated with a Buy at Mizuho
Mizuho initiated Enterprise Products with a Buy and a $32 price target.
11/16/16
LTCO
11/16/16
INITIATION
Target $30
LTCO
Buy
Enterprise Products initiated with a Buy at Ladenburg
Ladenburg Thalmann analyst Michael Schmitz started Enterprise Products Partners with a Buy rating and $30 price target.
MNST Monster Beverage
$45.26

1.67 (3.83%)

09/16/16
09/16/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. GoPro (GPRO) initiated with a Buy at BofA/Merrill. 2. JetBlue (JBLU) initiated with an Outperform at Imperial Capital. 3. PepsiCo (PEP), Dr Pepper Snapple (DPS), and Monster Beverage (MNST) were initiated with an Outperform at Credit Suisse, while the firm initiated Boston Beer (SAM) with an Underperform. Credit Suisse also initiated Coca-Cola (KO) and Constellation Brands (STZ) with a Neutral. 4. lululemon (LULU) initiated with a Positive at Susquehanna. 5. Target (TGT) coverage assumed with a Neutral at Credit Suisse. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/04/16
STFL
11/04/16
NO CHANGE
STFL
Monster Beverage results 'better than feared,' says Stifel
Although Monster's Q3 results came in below expectations, they were "better than feared," according to Stifel analyst Mark Astrachan. The analyst blames the miss partly on higher expenses and shipment timing. He notes that the company's gross sales accelerated meaningfully in October versus Q3, and he thinks that its U.S. market remains strong. The analyst trimmed his price target on the name to $178 from $185 and keeps a Buy rating.
11/04/16
RBCM
11/04/16
NO CHANGE
RBCM
Monster Beverage 'bull case still intact,' says RBC Capital
After Monster (MNST) reported weaker than expected results, RBC Capital analyst Nik Modi blames the miss partially on the company's transition to Coca-Cola's (KO) system. The analyst says that the company was off to a strong start in October, and he continues to believe that its growth will be boosted by innovation. He keeps an Outperform rating on the shares.
10/20/16
STFL
10/20/16
NO CHANGE
STFL
Monster Beverage should be bought on recent weakness, says Stifel
Stifel analyst Mark Astrachan continues to expect Monster's sales to rise by at least high single digit percentage levels through at least 2018, partly driven by international expansion and innovation. The analyst attributes recent weakness in the stock to a lack of new products by the company and perceptions of decelerating energy drink growth. But he thinks the U.S. energy drink category "remains healthy," and he says that Monster is poised to offer new products. He recommends buying the shares on weakness and keeps a $185 price target and Buy rating on the stock.

TODAY'S FREE FLY STORIES

PDS

Precision Drilling

09:30
12/07/16
12/07
09:30
12/07/16
09:30
Upgrade
Precision Drilling rating change  »

Precision Drilling…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

KTOV

Kitov Pharmaceuticals

$3.44

0.05 (1.47%)

09:27
12/07/16
12/07
09:27
12/07/16
09:27
Hot Stocks
Kitov Pharmaceuticals completes all KIT-302 testing to file NDA »

Kitov…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNCFF

UniCredit

$2.47

0.28 (12.79%)

09:25
12/07/16
12/07
09:25
12/07/16
09:25
Periodicals
Pioneer suspends a pair of senior Dublin execs, Irish Times reports »

UniCredit's Pioneer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARIA

ARIAD

$13.69

0.41 (3.09%)

09:25
12/07/16
12/07
09:25
12/07/16
09:25
Conference/Events
ARIAD to hold a conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 29

    Apr

OCLR

Oclaro

$8.35

-0.05 (-0.60%)

09:25
12/07/16
12/07
09:25
12/07/16
09:25
Conference/Events
Oclaro participates in a conference call with Jefferies »

Conference call with CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

SBUX

Starbucks

$57.44

-0.06 (-0.10%)

09:24
12/07/16
12/07
09:24
12/07/16
09:24
Hot Stocks
Starbucks says sees at-home coffee sales growth slowing »

Cites fewer Keurig sales.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

WDC

Western Digital

$63.85

1.76 (2.83%)

, SQ

Square

09:23
12/07/16
12/07
09:23
12/07/16
09:23
Hot Stocks
On The Fly: Pre-market Movers »

HIGHER: Anthera…

WDC

Western Digital

$63.85

1.76 (2.83%)

SQ

Square

AAPL

Apple

$109.95

0.84 (0.77%)

PLAY

Dave & Buster's

$48.00

-0.83 (-1.70%)

VRA

Vera Bradley

$14.67

-0.07 (-0.47%)

ANTH

Anthera

$1.47

-0.03 (-2.00%)

SIGM

Sigma Designs

$7.75

0.1 (1.31%)

SSNLF

Samsung

AVAV

AeroVironment

$29.34

0.76 (2.66%)

OXM

Oxford Industries

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 07

    Dec

  • 07

    Dec

  • 07

    Dec

  • 08

    Dec

  • 14

    Dec

  • 09

    Jan

  • 09

    Jan

  • 13

    Mar

WDAY

Workday

09:23
12/07/16
12/07
09:23
12/07/16
09:23
Downgrade
Workday rating change  »

Workday downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 09

    Jan

AAPL

Apple

$109.95

0.84 (0.77%)

, GOOG

Alphabet

$759.11

-3.41 (-0.45%)

09:21
12/07/16
12/07
09:21
12/07/16
09:21
Hot Stocks
Kantar says Apple iOS share gains driven by iPhone 7 sales »

Kantar Worldpanel ComTech…

AAPL

Apple

$109.95

0.84 (0.77%)

GOOG

Alphabet

$759.11

-3.41 (-0.45%)

GOOGL

Alphabet Class A

$776.18

-2.04 (-0.26%)

MSFT

Microsoft

$59.95

-0.27 (-0.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Jan

  • 13

    Mar

AZO

AutoZone

09:20
12/07/16
12/07
09:20
12/07/16
09:20
Recommendations
AutoZone analyst commentary  »

AutoZone price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

AAPL

Apple

$109.95

0.84 (0.77%)

09:18
12/07/16
12/07
09:18
12/07/16
09:18
Downgrade
Apple rating change  »

Apple downgraded to Mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Mar

SBUX

Starbucks

$57.44

-0.06 (-0.10%)

09:18
12/07/16
12/07
09:18
12/07/16
09:18
Hot Stocks
Starbucks says five-year goal is to 'elevate the brand' »

Also says goal is to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

NBR

Nabors Industries

09:16
12/07/16
12/07
09:16
12/07/16
09:16
Downgrade
Nabors Industries rating change  »

Nabors Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIT

Fitbit

09:16
12/07/16
12/07
09:16
12/07/16
09:16
Hot Stocks
Fitbit acquires certain assets from Pebble, deal excludes hardware products »

Fitbit announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

AVAV

AeroVironment

$29.34

0.76 (2.66%)

09:15
12/07/16
12/07
09:15
12/07/16
09:15
Hot Stocks
AeroVironment, Cal State Fresno to research water stress in almond trees »

AeroVironment announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:15
12/07/16
12/07
09:15
12/07/16
09:15
General news
Energy Action: NYMEX crude »

Energy Action: NYMEX…

CLB

Core Laboratories

09:13
12/07/16
12/07
09:13
12/07/16
09:13
Downgrade
Core Laboratories rating change  »

Core Laboratories…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

ETFC

E-Trade

$35.52

0.31 (0.88%)

09:11
12/07/16
12/07
09:11
12/07/16
09:11
Hot Stocks
E-Trade CEO says running to grow company, not sell it »

Says running a company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

SBUX

Starbucks

$57.44

-0.06 (-0.10%)

09:09
12/07/16
12/07
09:09
12/07/16
09:09
Hot Stocks
Breaking Hot Stocks news story on Starbucks »

Starbucks says sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

S

Sprint

$8.17

0.12 (1.49%)

09:08
12/07/16
12/07
09:08
12/07/16
09:08
Hot Stocks
Sprint becomes first U.S. Pokemon GO partner »

Sprint and Niantic,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 04

    Jan

RES

RPC, Inc.

$21.39

-0.24 (-1.11%)

09:08
12/07/16
12/07
09:08
12/07/16
09:08
Downgrade
RPC, Inc. rating change  »

RPC, Inc. downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:07
12/07/16
12/07
09:07
12/07/16
09:07
Conference/Events
Cowen analysts hold an analyst/industry conference call »

Analysts hold an…

HBAN

Huntington Bancshares

$13.22

0.19 (1.46%)

09:07
12/07/16
12/07
09:07
12/07/16
09:07
Hot Stocks
Huntington Bancshares sees FY17 revenue growth of 20%+ »

Says implementation of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

OCRX

Ocera Therapeutics

$2.35

0.1 (4.44%)

09:05
12/07/16
12/07
09:05
12/07/16
09:05
Hot Stocks
Ocera Therapeutics completes enrollment in STOP-HE Phase 2b study »

Ocera Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIGM

Sigma Designs

$7.75

0.1 (1.31%)

09:05
12/07/16
12/07
09:05
12/07/16
09:05
Downgrade
Sigma Designs rating change  »

Sigma Designs downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.